About Protein naked cuticle homolog 2
Protein naked cuticle homolog 2 (NKD2) is a protein
from Homo sapiens identified by UniProt accession
Q969F2, 451 residues long.
MolForge cross-references it against 0 known binders and
53 disease associations.
Target properties
| Protein name | Protein naked cuticle homolog 2 |
| UniProt accession | Q969F2 |
| Gene | NKD2 |
| Organism | Homo sapiens |
| Length | 451 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (53)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.41
- erythrocyte count · score 0.39
- Red cell distribution width · score 0.39
- mean corpuscular hemoglobin concentration · score 0.38
- hemoglobin measurement · score 0.32
- red blood cell density measurement · score 0.25
- PR interval · score 0.21
- drug use measurement · score 0.10
- acute myeloid leukemia · score 0.07
- neoplasm · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q969F2-F1 | alphafold | PREDICTED | 55.45 | — |
Amino-acid sequence (451 residues)
MGKLQSKHAA AARKRRESPE GDSFVASAYA SGRKGAEEAE RRARDKQELP NGDPKEGPFR EDQCPLQVAL PAEKAEGREH PGQLLSADDG ERAANREGPR GPGGQRLNID ALQCDVSVEE DDRQEWTFTL YDFDNCGKVT REDMSSLMHT IYEVVDASVN HSSGSSKTLR VKLTVSPEPS SKRKEGPPAG QDREPTRCRM EGELAEEPRV ADRRLSAHVR RPSTDPQPCS ERGPYCVDEN TERRNHYLDL AGIENYTSRF GPGSPPVQAK QEPQGRASHL QARSRSQEPD THAVHHRRSQ VLVEHVVPAS EPAARALDTQ PRPKGPEKQF LKSPKGSGKP PGVPASSKSG KAFSYYLPAV LPPQAPQDGH HLPQPPPPPY GHKRYRQKGR EGHSPLKAPH AQPATVEHEV VRDLPPTPAG EGYAVPVIQR HEHHHHHEHH HHHHHHHFHP S
Explore Protein naked cuticle homolog 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets